{
    "ticker": "POAI",
    "name": "Predictive Oncology Inc.",
    "description": "Predictive Oncology Inc. is a pioneering biotechnology company that leverages artificial intelligence and machine learning to improve cancer treatments and outcomes. Founded in 2018, the company focuses on developing personalized medicine solutions by analyzing tumor samples and predicting how patients will respond to various therapies. Predictive Oncology utilizes its proprietary AI platform, which combines vast amounts of patient data with advanced analytics, to inform treatment decisions and optimize therapeutic strategies. The company's mission is to enhance the efficiency of drug development and to provide oncologists with tools that can lead to more effective, personalized treatment plans for cancer patients. Through strategic collaborations and partnerships with leading research institutions, Predictive Oncology aims to revolutionize cancer care by integrating cutting-edge technology into traditional clinical practices. The company is committed to driving innovation in oncology and offers solutions that address the urgent need for more tailored cancer therapies.",
    "industry": [
        "Biotechnology",
        "Healthcare"
    ],
    "headquarters": "Minneapolis, Minnesota, USA",
    "founded": "2018",
    "website": "https://www.predictive-oncology.com",
    "ceo": "Dr. Carl Schwartz",
    "social_media": {
        "twitter": "https://twitter.com/PredictiveOnc",
        "linkedin": "https://www.linkedin.com/company/predictive-oncology-inc/"
    },
    "investor_relations": "https://www.predictive-oncology.com/investor-relations",
    "key_executives": [
        {
            "name": "Dr. Carl Schwartz",
            "position": "CEO"
        },
        {
            "name": "Dr. Mark J. L. Gunter",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "AI-Driven Oncology Solutions",
            "products": [
                "Predictive Analytics Platform",
                "Tumor Response Prediction"
            ]
        },
        {
            "category": "Clinical Services",
            "products": [
                "Personalized Cancer Treatment Plans",
                "Biomarker Analysis"
            ]
        }
    ],
    "seo": {
        "meta_title": "Predictive Oncology Inc. | AI-Driven Cancer Solutions",
        "meta_description": "Discover Predictive Oncology Inc., a leader in AI-driven cancer treatment solutions. Explore innovative analytics to enhance personalized medicine.",
        "keywords": [
            "Predictive Oncology",
            "Artificial Intelligence",
            "Cancer Treatment",
            "Personalized Medicine",
            "Biotechnology",
            "Oncology"
        ]
    },
    "faq": [
        {
            "question": "What does Predictive Oncology do?",
            "answer": "Predictive Oncology uses AI and machine learning to develop personalized medicine solutions for cancer treatment."
        },
        {
            "question": "Who is the CEO of Predictive Oncology?",
            "answer": "Dr. Carl Schwartz is the CEO of Predictive Oncology Inc."
        },
        {
            "question": "Where is Predictive Oncology headquartered?",
            "answer": "Predictive Oncology is headquartered in Minneapolis, Minnesota, USA."
        },
        {
            "question": "What are the main products of Predictive Oncology?",
            "answer": "The main products include an AI-driven predictive analytics platform and personalized cancer treatment plans."
        },
        {
            "question": "When was Predictive Oncology founded?",
            "answer": "Predictive Oncology was founded in 2018."
        }
    ],
    "competitors": [
        "CRIS",
        "RGEN",
        "SGEN",
        "EDIT"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "BMY",
        "JNJ"
    ]
}